Abiopharma

FDA approve TRETINOIN

Riverstone Holdings Limited - Announcement

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

EHC INVESTIGATION ALERT: Investigation Launched into Encompass Health Corporation, Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards

New Form 4 - Monopar Therapeutics Filed: 2025-07-16 AccNo: 0001437749-25-022863 Size: 10 KB

New Form 4 - Monopar Therapeutics Filed: 2025-07-16 AccNo: 0001437749-25-022862 Size: 9 KB

New Form 4 - Monopar Therapeutics Filed: 2025-07-16 AccNo: 0001437749-25-022861 Size: 9 KB

New Form 4 - Shattuck Labs, Inc. Filed: 2025-07-16 AccNo: 0001104659-25-068454 Size: 7 KB

New Form 4 - ADMA BIOLOGICS, INC. Filed: 2025-07-16 AccNo: 0001140361-25-026099 Size: 13 KB

New Form 4 - Shattuck Labs, Inc. Filed: 2025-07-16 AccNo: 0001104659-25-068453 Size: 9 KB

NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards

IPA présentera 29 juillet 2025 ses résultats financiers et les faits saillants de ses activités récentes pour le quatrième trimestre et lensemble de lexercice 2025